chrisvoncsefalvay/vaers-outcomes huggingface dataset:
arm went numb down to the tips of my fingers/Felt like circulation in my forearm down to my fingers had been cut off/As soon as he injected me with the vaccine, my arm went numb; experienced something very strange/very strange feeling/every now and then I get the weird sensation that it's getting numb again; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (arm went numb down to the tips of my fingers/Felt like circulation in my forearm down to my fingers had been cut off/As soon as he injected me with the vaccine, my arm went numb) and FEELING ABNORMAL (experienced something very strange/very strange feeling/every now and then I get the weird sensation that it's getting numb again) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 vaccination.     The medical history was not provided by the reporter.  Concomitant products included BUPROPION HYDROCHLORIDE (WELLBUTRIN) for an unknown indication.    On 30-Jun-2021 at 11:20 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jun-2021, the patient experienced HYPOAESTHESIA (arm went numb down to the tips of my fingers/Felt like circulation in my forearm down to my fingers had been cut off/As soon as he injected me with the vaccine, my arm went numb) and FEELING ABNORMAL (experienced something very strange/very strange feeling/every now and then I get the weird sensation that it's getting numb again). At the time of the report, HYPOAESTHESIA (arm went numb down to the tips of my fingers/Felt like circulation in my forearm down to my fingers had been cut off/As soon as he injected me with the vaccine, my arm went numb) and FEELING ABNORMAL (experienced something very strange/very strange feeling/every now and then I get the weird sensation that it's getting numb again) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information, if any, was not provided   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Addition information included primary reporter address, patient details, Added suspect dose batch number, date and route of administration, Added concomitant medicine, Added event dates and outcome.
patient said 8 days after 1st shot got a small rash lower on her arm (small red dots and itchy). then moved over the next 2-3 days to upper arm. did not require treatment. spoke with primary care who advised ok to give second dose
Pt recvd 3rd dose of vax 08NOV90 & did not seroconvert p/antibodies were checked "several" times;
Local skin reaction large 12cm x 9cm, swollen hard, nodule formed near/around injection site. Pt instructed to use ice, TYLENOL, and BENADRYL if needed.
Exactly 2 weeks later, I was experiencing pain and red splotches on my upper back around my left side, Including my left breast.
Headache; Fever; chills; stomac upset; This is a spontaneous report from a contactable consumer (patient). A 71-year-old non-pregnant female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 17Feb2021 13:00 (Batch/Lot Number: EL9266) as single dose for covid-19 immunisation administered in Doctor's office/urgent care. Medical history included, food allergy of scallops, crab, tetracycline, erythromycin and experienced drug hypersensitivity, blood pressure increased, gastroesophageal reflux disease, diverticulitis. Historical vaccine included, bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 28Jan2021 13:15 (Batch/Lot Number: EN9581) as single dose for covid-19 immunisation. Concomitant medication(s) in two weeks included omeprazole; hydrochlorothiazide and vitamin. On 17Feb2021 18:00, the patient experienced headache, fever, chills, stomach upset. Fever has lasted more than day and a half, so far. Chills lasted one day. Headache more than 2 days. The patient did not receive any treatment for the event. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient diagnosed with COVID-19 was unknown; Since the vaccination, the patient not been tested for COVID-19. The outcome of events was not recovered.
I've now had 3 Pfizer vaccinations, the booster was 12/28/21  and pain, stiffness and locking of my hands has been more progressed with each dose. I've never had any issues with this, very healthy, prior to the 1st dose of Pfizer. I have co-workers who are also experiencing the same thing
Gave DTAPHBIP (PEDIARIX) to 13 yr should have given Tdap, Hep B and IVP.
developed COVID19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (developed COVID19) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History Information was reported.     On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced COVID-19 (developed COVID19). At the time of the report, COVID-19 (developed COVID19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Feb-2021, SARS-CoV-2 test positive: positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 18-Feb-2021 and was forwarded to Moderna on 19-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (developed COVID19) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History Information was reported.     On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced COVID-19 (developed COVID19). At the time of the report, COVID-19 (developed COVID19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Feb-2021, SARS-CoV-2 test positive: positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Rash on her back that is itchy and is spreading; This case was reported by a consumer via call center representative and described the occurrence of itchy rash in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included aneurysm cerebral. Concurrent medical conditions included back pain and degenerative joint disease.   On 20th November 2019, the patient received Shingrix. On an unknown date, less than a month after receiving Shingrix, the patient experienced itchy rash. On an unknown date, the outcome of the itchy rash was not recovered/not resolved.   It was unknown if the reporter considered the itchy rash to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The patient received Shingrix and had a rash on her back that was itchy and was spreading.She did not know exactly when the rash started in relation to receiving the vaccine but insists it did not start until after receiving the vaccine.She also indicated that she has had the rash for almost one month. The reporter unable to obtain additional information and reporter ended the call.
Severe and persistent sensitivity to sun exposure on neck. Patient received a mild sunburn that broke out into a severe rash similar to sun poisoning. Rash is very itchy
Extreme fatigue, arm pain, neck pain. Had to miss work for the 1st time in 6 years. Fever
Pt immediately stated that she felt "funny" --I asked if she was lightheaded or dizzy and she said yes. I sent my tech to get her some orange juice as I felt it might be low sugar. As I turned back around, the patient's arm started twitching and her head lolled to the side. Her eyes rolled into her head and her mouth hung open. She was unresponsive to both verbal and physical stimulation. I called to my intern to dial 911 and returned my attention to the patient. At this time, she suddenly opened her eyes and was able to speak to me candidly, though she had no recollection of the incident. I still had medical personnel come to check her vitals. It was determined that patient had low blood sugar at the time of the incident. She will follow up with her doctor to retest labs. Pt fine after eating and resting. Follow up phone call 3 hours later found patient well.
rash all over the back and stomach; rash all over the back and stomach was reported as worsened; itching around the arm and down; pain in the chest and a heavy feeling; pain in the chest and a heavy feeling; I am also under stress.; This is a spontaneous report from a contactable consumer (patient). A 41-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EW0198, Expiration Date: unknown), dose 2 via an unspecified route of administration, administered in Arm Left on 23Jul2021 14:00 (at the age of 41-year-old) as dose 2, single for COVID-19 immunization. The patient medical history was none reported. The patient's concomitant medications were not reported. The patient previously received first dose of BNT162B2 (Solution for injection, Lot Number: EW0185; Expiration Date: Unknown), administered in Left Arm on 02Jul2021 (at the age of 41-year-old) for COVID-19 immunization. Facility where COVID-19 vaccine was administered at Pharmacy. Patient Vaccination was not administered at Military Facility. Patient any additional vaccines administered on same date of the Pfizer Suspect was none reported. The patient received any other vaccines within 4 weeks prior to the COVID vaccine was none reported. Patient experienced adverse events prior vaccinations was none reported. Patient family medical history relevant to adverse events was none reported. Patient experienced rash all over the back and stomach was reported as worsened on an unspecified date in 2021. Patient stated received the second dose on 23Jul2021. A week later she started experiencing rash all over the back and stomach (30Jul2021) and noticed some itching around the arm and down (2021). Patient noticed once in a while a pain in the chest and a heavy feeling (2021). I could take breaths. I could also take deep breaths. I was also under stress (2021). Patient stated she was uncertain if she was having a side effect. She had the second vaccine a week ago this past Friday; for the last three days or so she has had a weird rash all over her stomach and back. Patient stated the rash began 30Jul2021, Friday. Stated it was getting worse. It was on her stomach and back, mentions that it was not on her bottom. Patient denied any other medical conditions, medications, labs, testing, or treatments relevant to report. Patient stated she was planning on calling her doctor once she spoke with someone at Pfizer. Verified she was calling to see if this was a side effect from the Covid Vaccine. Patient was not visited emergency room and physician office. There was no investigation assessment. Patient relevant tests were none reported. The clinical outcome of event was rash all over the back and stomach was not recovered and for another events outcome was unknown.  Follow-up activities closed. Batch/lot number available for [vaccine/BNT162B2].
Rash on shoulder, arm, chest and back.  Patient had follow-up with a dermatologist on 2/26/10 and was treated with Prednisone taper, and loratadine daily.
PT RECEIVED EXPIRED FLUMIST DURING WELL CHILD CHECK.  NO REPORTED ADVERSE EVENTS TO DATE OF CMOMPLETING REPORT.
blood clot; swelling and pain in right leg; swelling and pain in right leg; right arm hurting tremendously; This is a spontaneous report from a contactable Nurse. A 52-years-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Right on 01Apr2021 13:45; at the age of 52-years-old,  (Batch/Lot Number: ER8734) as SINGLE DOSE for covid-19 immunisation.  Medical history included ongoing hypertension, ongoing memory impairment (She states that she was diagnosed either last year or the year before that she can't remember. She states that it is ongoing, but it is well controlled). Historical vaccine included vaccine to tetanus (About 3 or 4 years ago). There were no concomitant medications.   The patient experienced blood clot (thrombosis) (disability) on 13Apr2021 with outcome of not recovered, swelling and pain in right leg (disability, medically significant) on 09Apr2021 with outcome of not recovered, right arm hurting tremendously (disability) on 01Apr2021 with outcome of recovered on 04Apr2021.   The patient underwent lab tests and procedures which included ultrasound scan: positive   on 13Apr2021 had a blood clot.  Therapeutic measures were taken as a result of blood clot (thrombosis) included Xarelto and due to pain in extremity the patient received ibuprofen (7 ibuprofen every day); Sender's Comments: Based on the information available and a close temporal association, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported events of Thrombosis. The case will be reassessed once new information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified.
Vaccine spilled on patient's arm; I dont think patient received any dose; crack in syringe and vaccine spill; A spontaneous report was received from a healthcare professional concerning a patient on an unknown age and gender who received Moderna's COVID-19 vaccine (mRNA-1273) and there was a crack in the syringe and the  vaccine spilled on patient's arm and don't think the patient received any dose.   The patient's medical history was not reported. No relevant concomitant medications were reported.     On 08-feb-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 for prophylaxis of COVID-19 infection.   On 08-feb-2021, pharmacy intern called to ask for some guidance for an incident that happened in the pharmacy. When they were vaccinating one of the patients, there was a crack in the syringe and the vaccine spilled on patient's arm. They did not think the patient received any dose. They wanted to know regarding the 2nd dose of vaccine and should they wait 4 weeks for it, and can patient absorb any vaccine topically.   Pharmacy intern didn't have any information about the patient because she wasn't the one who administered the vaccine. She said she will tell other people to report it. No treatment information was provided.    Consent for follow up was not given.   Action taken with mRNA-1273 in response to the events was not reported.    The outcome of the events and there was a crack in the syringe and the vaccine spilled on patient's arm and don't think the patient received any dose were considered resolved.; Reporter's Comments: This case concerns a patient of unknown age and gender who experienced NS unexpected events of Device connection issue, exposure via skin contact, and underdose with mRNA-1272 (lot # unknown) with no associated adverse events.  Events considered resolved.
PT recd vaxs in AM; in PM t105, became listless & had possible szs; mom brought to ER; PT had x-ray, blood work, & IV began; t101; PT then was admitted for observation; EEG & spinal tap;
Vaccine #1 - Received first dose of Moderna 1/14/2021  -- Ten-15 minutes after injection began to have lips and mouth tingling, wheezing, increase heart rate.  Told people at clinic.  They said to sit for another 15 minutes and come and get them if it got worse.  I went back after ~ 30 minutes total and a couple of medical assistants took my blood pressure.  It was  178/158 (normally I run 128/ 68).  They asked me to take my inhaler (Advair was all that I had so I took a dose).  In addition they gave me one Benadryl tablet (25 mg). 1 hour 20 minutes later my heart rate was 157/124 they gave me another Benadryl to take on my way home if I needed it. *** When I got to my home 30-40 minutes away.  I called my internist. I spoke with her nurse and they called back and told me to take my second dose of 25 mg Benadryl.  She told me to take 25 to 50 mg of Benadryl one hour before getting my second dose of Moderna vaccine.  I had significant swelling on the injection site 3-4 inches in diameters that went down after 5-6/days.  Vaccine # 2 - I received my second dose of Moderna 2/19/2021.  I took 25mg Benadryl ~ 30 minutes before vaccine and took the additional 25 mg when I returned home.  I was extremely cold and could not get warm for 48 hours I took Tylenol. There was no fever. I had wheezing. Swelling day #1 was 1-2 inches Days 2-5 swelling was 4-5.5 inches in diameter. Five to seven days later the swelling and pain resolved.
10 patients received Moderna vaccine that had thawed out and then refroze; 10 patients received Moderna vaccine that had thawed out and then refroze; The patients are all adults the patients have not reported other side effects; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT STORAGE ERROR (10 patients received Moderna vaccine that had thawed out and then refroze), POOR QUALITY PRODUCT ADMINISTERED (10 patients received Moderna vaccine that had thawed out and then refroze) and NO ADVERSE EVENT (The patients are all adults the patients have not reported other side effects) in an adult patient of an unknown gender who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (10 patients received Moderna vaccine that had thawed out and then refroze), POOR QUALITY PRODUCT ADMINISTERED (10 patients received Moderna vaccine that had thawed out and then refroze) and NO ADVERSE EVENT (The patients are all adults the patients have not reported other side effects). At the time of the report, PRODUCT STORAGE ERROR (10 patients received Moderna vaccine that had thawed out and then refroze), POOR QUALITY PRODUCT ADMINISTERED (10 patients received Moderna vaccine that had thawed out and then refroze) and NO ADVERSE EVENT (The patients are all adults the patients have not reported other side effects) outcome was unknown.        For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter considered NO ADVERSE EVENT (The patients are all adults the patients have not reported other side effects) to be not related. No further causality assessments were provided for PRODUCT STORAGE ERROR (10 patients received Moderna vaccine that had thawed out and then refroze) and POOR QUALITY PRODUCT ADMINISTERED (10 patients received Moderna vaccine that had thawed out and then refroze).    No relevant concomitant medications were reported. No treatment medication reported.   This case was for the 5th patient out of 10 reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-743056 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-743056:Master case
Patient got a fever after getting hepatitis A and flu shot on 3/10/2016. I gave Motrin to control fever and kept him home from school on 3/11/2016. Fever continued all day on 3/11/16 and I gave Motrin around the clock. 3/12/16 at around 2:00 AM he started screaming and crying that he was itching. No rashes, hives, or marks are on his body but he keeps complaining of itching. Checked in to Hospital and patient was admitted. He continues to cry and complain of itching even after the medicines the hospital is giving him. Nothing is working. Please help. None of this happened until the shots.
Severe shaking, nausea, facial numbness, SOB. Went to ER and given Benadryl. Neck stiffness.
swollen lymph nodes in right armpit appeared after about 24 hours from vaccination, the bulge grew the size of chicken egg  over th e next 2 days+ fullness/swollen ear canals, both ears. arm pit nodes returned to almost normal condition after 5 days from onset of symptoms, some discomfort remains under armpit but transient (sometime tender nodes are present and other times not). swollen ears remains a problem 2.5 weeks later, partial hearing loss due to swelling. no medical treatments
Case number PHEH2014US017089, is an initial spontaneous report received from a pharmacist on 22 Aug 2014. This report refers to a male patient over 65 years old. His medical history included spleen removed. The pharmacist reported that he realized that their protocol for meningococcal vaccination of asplenic patients was out of date. And one of the doctors incorrectly gave this patient MENOMUNE (batch number unknown, other manufacturer) intramuscularly instead of MENVEO (batch number: unknown) on an unknown date. No adverse event was reported. No further information was provided.
booster doses administered after expiration date; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (booster doses administered after expiration date) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (booster doses administered after expiration date). On 11-Nov-2021, EXPIRED PRODUCT ADMINISTERED (booster doses administered after expiration date) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided. List of concomitant medication were not given.  Vaccine were given on 8, 9, 10, 11, 12, 15, 16, 17, 18, 19 and 22 of November. HCP did not have # of doses given each day but said that on average, 6-7 doses were given per day; "it is possible we had used 2 vials in the same day", HCP added. All booster doses were injected intramuscularly in deltoid muscle.
arm  achiness; This case was reported by a nurse via call center representative and described the occurrence of pain in arm in a 49-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number MF9EA, expiry date 1st June 2021) for prophylaxis.   On 15th April 2019, the patient received Boostrix. In May 2019, 7 days after receiving Boostrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was not recovered/not resolved.   It was unknown if the reporter considered the pain in arm to be related to Boostrix.  Additional case details were provided as follows: The patient received Boostrix on the right arm. One week later, the patient's arm was ached.  It was the same arm where the injection was given.   He described it as feeling like he had been punched in the arm. No other visible reactions were seen.  No redness or swelling.   The reporter consented to follow up.
Local reaction at injection site; & pain redness, swelling of upper arm expanding several inches from injection site (upper arm to elbow). Pruritis. Tx - cold compress & diphenhydramine 25-50mg Q6 prn.
States developed stiffness and aching of joints with severe fatigue, started around 12/3/02.